CAR T-Cell Therapies: Idecabtagene Vicleucel and Ciltacabtagene Autoleucel
Elotuzumab
Teclistamab-cqyv
(UPDATE) Ixazomib
Multiple Myeloma Research Foundation (MMRF)
NCCN Patient Resources
International Myeloma Foundation (IMF)
Myeloma Central